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POLLY J. FERGUSON,8 B. ANNE EBERHARD,9 HERMINE I. BRUNNER,10 SAMPATH PRAHALAD,11
RAYFEL SCHNEIDER,12 AND PETER A. NIGROVIC,13 FOR THE AMERICAN COLLEGE OF
RHEUMATOLOGY SPECIAL COMMITTEE ON PEDIATRICS AND THE INVESTIGATORS OF THE
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Objective. The small size of many pediatric rheumatology programs translates into limited mentoring options for early career
physicians. To address this problem, the American College of Rheumatology (ACR) and the Childhood Arthritis and Rheumatol-
ogy Research Alliance (CARRA) developed a subspecialty-wide interinstitutional mentoring program, the ACR/CARRA Men-
toring Interest Group (AMIGO). We sought to assess the impact of this program on mentoring within pediatric rheumatology.
Methods. In a longitudinal 3-year study, participant ratings from the AMIGO pilot program were compared with those
after the program was opened to general enrollment. Access to mentoring as a function of career stage was assessed by
surveys of the US and Canadian pediatric rheumatologists in 2011 and 2014, before and after implementation of AMIGO.
Results. Participants in the pilot phase (19 dyads) and the general implementation phase (112 dyads) reported compara-
ble success in establishing mentor contact, suitability of mentor-mentee pairing, and benefit with respect to career develop-
ment, scholarship, and work-life balance. Community surveys showed that AMIGO participation as mentee was high
among fellows (86%) and modest among junior faculty (31%). Implementation correlated with significant gains in breadth
of mentorship and in overall satisfaction with mentoring for fellows but not junior faculty.
Conclusion. AMIGO is a career mentoring program that serves most fellows and many junior faculty in pediatric rheumatol-
ogy across the US and Canada. Program evaluation data confirm that a subspecialty-wide interinstitutional mentoring pro-
gram is feasible and can translate into concrete improvement in mentoring, measurable at the level of the whole professional
community.
INTRODUCTION
Mentoring refers to an extended relationship through which
a person of advanced professional standing guides a more
junior colleague toward career success (1). Within medi-
cine, mentoring usually targets academic advancement, but
it may also foster success in nonacademic aspects of pro-
fessional life, such as work-life balance (2,3). Recognizing
the critical role of mentoring in academic medicine, aca-
demic and professional institutions increasingly seek to
formalize this process to ensure that trainees and junior
faculty receive appropriate guidance (4–6). However, doc-
The American College of Rheumatology (ACR) and the
Childhood Arthritis and Rheumatology Research Alliance
(CARRA) provided support for the ACR/CARRA Mentoring
Interest Group. Dr. Nigrovic’s work was supported by the
Cogan Family Foundation and the Fundacion Bechara.
1Lakshmi Nandini Moorthy, MD, MS: Rutgers University
Robert Wood Johnson Medical School, New Brunswick, New
Jersey; 2Eyal Muscal, MD, MS: Texas Children’s Hospital,
Baylor University College of Medicine, Houston; 3Meredith
Riebschleger, MD, MS: University of Michigan, Ann Arbor;
4Marisa Klein-Gitelman, MD: Anne & Robert H. Lurie Child-
ren’s Hospital of Chicago, Chicago, Illinois; 5Lise E. Nigrovic,
MD, MPH: Boston Children’s Hospital, Boston, Massachusetts;
6Jeffrey R. Horon, MBA: Elsevier Research Intelligence, New
York, New York; 7Kelly Rouster-Stevens, MD: Emory Univer-
sity School of Medicine, Atlanta, Georgia; 8Polly J. Ferguson,
MD: University of Iowa Carver College of Medicine, Iowa
City; 9B. Anne Eberhard, MBBS, MSc: Hofstra–North Shore–
Long Island Jewish School of Medicine, North Shore, New
York; 10Hermine I. Brunner, MD, MSc: Cincinnati Children’s
Hospital Medical Center and University of Cincinnati College
of Medicine, Cincinnati, Ohio; 11Sampath Prahalad, MD,
MSc: Emory University School of Medicine and Children’s
Healthcare of Atlanta, Atlanta, Georgia; 12Rayfel Schneider,
MBBCh: University of Toronto and the Hospital for Sick
Children, Toronto, Ontario, Canada; 13Peter A. Nigrovic, MD:
Boston Children’s Hospital and Brigham and Women’s Hospi-
tal, Boston, Massachusetts.
Address correspondence to Peter A. Nigrovic, MD, Division
of Rheumatology, Immunology and Allergy, Brigham and
Women’s Hospital, Smith 516B, One Jimmy Fund Way, Boston,
MA 02115. E-mail: pnigrovic@partners.org.
Submitted for publication July 20, 2015; accepted
September 8, 2015.
645
umenting the success of mentoring programs has proven
to be a major challenge (2,6,7).
Within rheumatology, lack of effective mentoring is in-
creasingly recognized as a barrier to academic success (8–11).
Pediatric rheumatology presents a particular challenge for
early career physicians seeking subspecialty-specific mentors,
because most programs are small and therefore offer few local
options (12,13). Further, nearly all pediatric rheumatologists
practice within teaching hospitals and therefore must negoti-
ate an academic career. Surveys of fellows and junior faculty
correspondingly identify mentoring as a major unmet career
need in pediatric rheumatology (14,15).
Recognizing this mentorship gap, the 2 major profession-
al organizations serving North American pediatric rheuma-
tology, the American College of Rheumatology (ACR) and
the Childhood Arthritis and Rheumatology Research Alli-
ance (CARRA), developed the ACR/CARRA Mentoring
Interest Group (AMIGO) (14). AMIGO includes 2 interven-
tions. First, educational/networking sessions are held at
each ACR and CARRA annual scientific meeting to address
common problems facing early career pediatric rheumatol-
ogists. Second, an interinstitutional mentoring program
pairs interested fellows and junior faculty with volunteer
career mentors at different centers. A pilot program consist-
ing of 20 mentee-mentor dyads was launched in November
2011, and yearly cycles of enrollment have been open to all
fellows and junior faculty since that time.
To assess the impact of AMIGO, a 2-part program evalu-
ation strategy was designed. First, participants were sur-
veyed to assess measures of process adequacy and self-
reported benefits. Second, US and Canadian pediatric
rheumatologists were surveyed before and after imple-
mentation to identify associated changes at the level of the
whole community. The implementation and evaluation of
AMIGO are reported here.
MATERIALS AND METHODS
The AMIGO program. AMIGO mentees and mentors
were recruited by notices on the highly subscribed
McMaster University pediatric rheumatology listserve and
the ACR’s Pediatric Rheumatology listserve, by announce-
ments at meetings, and by direct email to US and Canadian
division heads, program directors, and other community
leaders. Fellows were encouraged to enroll during their ini-
tial year of subspecialty training, and junior faculty (defined
as assistant professor and below) could participate as ment-
ees until achievement of the rank of associate professor or
R01-level funding. All interested mentees were accommo-
dated during each annual cycle. Mentors were selected
from faculty volunteers elicited as above.
Matching was performed using a computer algorithm
based on responses of prospective mentees and mentors to
an online questionnaire. The algorithm proposed 5 candi-
date mentors for each mentee, after evaluating all potential
dyads for compliance to program rules (mentees and men-
tors could not be affiliated with the same institution; mentors
had to be of higher academic rank) and fit to mentee requests
for mentor characteristics, including general career track
(clinician/educator, clinical researcher, basic researcher),
mentor sex, and specific expertise areas, such as balancing
home and family or working part time. If mentors were not
sufficiently differentiated by these criteria, overlap between
mentee- and mentor-expressed research interests and
disease-area interests were employed. In general, fellows
were matched with junior faculty mentors, and junior faculty
mentees were matched with senior faculty (defined as asso-
ciate and full professors). Junior faculty could participate
simultaneously as mentee and mentor. More senior mentors
could be assigned 2 mentees. Final matches were adjudicat-
ed by a volunteer AMIGO Steering Committee, which was
guided but not bound by the algorithm results. Mentorship
duration was set at 3 years. Mentors were not compensated
for AMIGO participation.
Once assigned, mentees and mentors were introduced by
email and encouraged to exchange curricula vitae. A men-
toring tool kit of related guidance was provided (https://
www.rheumatology.org/Education/Careers/AMIGO/).
Dyads received periodic email reminders to maintain con-
tact. The manner, frequency, and content of mentor-mentee
interactions were left to the discretion of participants.
AMIGO participant surveys. AMIGO mentees and
mentors provided email addresses that were used to direct
participants to anonymous online surveys using the Qual-
trics interface (Qualtrics, LLC). The first survey, in March
2013, included only 2011 pilot dyads. The second survey,
of all AMIGO participants, was conducted from December
2013 to January 2014. Participants were asked to report
whether and how dyads had interacted to discuss the
mentee’s career, whether the skill set of the mentor was
appropriate to address needs of the mentee, as assessed by
the participants (termed mentor-mentee fit), whether the
mentee experienced benefit in specific domains related to
professional life, and whether the interaction was ex-
pected to prove helpful to the mentee.
Surveys of the pediatric rheumatology community. To
evaluate the impact of AMIGO on the community as a
whole, US and Canadian pediatric rheumatologists were
directed from the McMaster University and ACR listserves
Significance & Innovations
 The American College of Rheumatology/Childhood
Arthritis Research and Rheumatology Alliance
Mentoring Interest Group (AMIGO) is an interinsti-
tutional mentoring program that includes most fel-
lows and many junior faculty in US and Canadian
pediatric rheumatology.
 AMIGO mentees report that participation bene-
fits multiple aspects of career development.
 Surveys of the pediatric rheumatology community
before and after AMIGO identify overall improve-
ment in the mentoring environment for pediatric
rheumatology fellows, representing the first objec-
tive outcomes data for any mentoring program in
medicine.
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to anonymous online Qualtrics surveys. Participants were
asked to respond only once. The first survey was adminis-
tered from December 2011 to January 2012; participants
who had just enrolled in the AMIGO pilot phase (Novem-
ber 2011) were asked to provide pre-AMIGO answers. The
second survey was administered via the same channels
between February and March 2014. Participants were
asked to report access to a mentor in specific career
domains at the home institution, at an outside institution,
both, or neither, and to rate overall satisfaction with the
career mentoring.
Statistical analysis. Significance of differences between
proportions was calculated using chi-square or Fisher’s
exact test as appropriate. Data were prepared using SPSS
software and analyzed using GraphPad Prism software.
Institutional Review Board approval. Surveys of AMIGO
participants were considered program evaluation and
therefore not subject to review per the guidelines of the
Brigham and Women’s Hospital. Anonymous surveys of
the general pediatric rheumatology community were con-
sidered exempt human subjects research by institutional
review boards at the University of Michigan and the Rob-
ert Wood Johnson Medical School.
RESULTS
AMIGO pilot phase implementation and assessment.
The AMIGO pilot program was launched in November
2011 with 20 mentee-mentor dyads. Pilot mentee partici-
pants were selected randomly from among 60 interested
fellow and junior faculty, and paired with 1 of 45 volun-
teer faculty mentors. One dyad dissolved due to the ment-
ee’s departure from North America. The remaining 19
dyads were surveyed after 17 months to ascertain the
dynamics and potential benefit of the interaction
(response rate 37 of 38, 97%). Mentor-mentee fit was gen-
erally good (Figure 1A). All dyads made contact at least
once to discuss the mentee’s career, and the majority
reported 2 or more interactions, though total duration of
contact was often modest (Figure 1B–C). As previously
reported, mentees reported benefit in domains including
career development and scholarship, while mentors
reported an improved sense of connection to the commu-
nity and enhancement of their teaching profiles (14).
AMIGO general implementation and assessment.
AMIGO was opened to general enrollment in 2012. A total
of 57 dyads were matched in November 2012 and 38 in
November 2013, drawing mentors from a pool of 52 volun-
teers in 2012 and 36 in 2013. All AMIGO participants
were surveyed by email between December 2013 and Janu-
ary 2014. Respondents included 77 of 112 mentees (69%
response rate, including 7 who were also mentors). Given
the highly variable duration since match (16 mentees in
2011, 28 mentees in 2012, and 33 mentees in 2013), the
survey did not attempt to assess frequency and duration of
mentor-mentee interactions. However, mentor-mentee fit
was comparable to that reported in the AMIGO pilot (Fig-
ure 1D). Mentees reported that 95% of dyads (69 of 73
respondents) had engaged in at least 1 discussion regard-
ing the mentee’s career, generally within the last 2–6
Figure 1. American College of Rheumatology/Childhood Arthritis Research and Rheumatology
Alliance Mentoring Interest Group process measures in pilot phase and general implementation.
(A–C) Pilot phase 17 months after initial match (mentees and mentors [n 5 39]). m 5 minutes;
h 5 hours. (D–F) General implementation (mentor-mentee fit [n 5 140 mentees and mentors],
most recent interaction with mentor [n 5 73 mentees], whether pairing was likely to prove benefi-
cial to mentee [n 5 138 mentees and mentors]).
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months, including approximately 90% who reported hav-
ing met in person (Figure 1E, and data not shown). Assess-
ment of overall benefit to mentees was comparable in pilot
and general implementation phases (Figure 1F).
Mentees were asked to report perceived benefit from
AMIGO in specific career domains. Gains were most fre-
quently reported in career development, scholarship,
work-life balance, and connectedness to the pediatric
rheumatology community (Figure 2). These results are
concordant with findings from the pilot phase (14).
Pediatric rheumatology community survey results. To
assess the effect of AMIGO on mentoring for early career
rheumatologists, we performed pre-AMIGO (2011) and
post-AMIGO (2014) surveys of the US and Canadian pedi-
atric rheumatology community. Characteristics of the
respondents are enumerated in Table 1. Since surveys
were administered by listserve, we were unable to calcu-
late absolute response rates. However, the US and Canadi-
an pediatric rheumatology community includes fewer
than 350 faculty and fellows, such that response rates
exceeded 50% for both surveys. Respondent populations
were comparable across surveys (Table 1). In the 2014 sur-
vey, 86% of fellow respondents reported participating in
AMIGO, whereas fewer junior faculty participated as
mentees (31% participated as mentees and 29% as men-
tors, including 10% as both mentees and mentors).
Respondents at all career levels were asked to report
access to mentoring in domains relevant to academic
rheumatology: clinical practice, teaching, research, setting
career goals, and identifying how to achieve career goals
(Figure 3). In both 2011 and 2014 surveys, most fellows
and junior faculty acknowledged having a mentor of some
kind in each domain. In 2011, fellows were much less
likely than senior faculty to have mentors outside their
home institutions (P , 0.05 in all categories except teach-
ing and how to achieve career goals) (Figure 3, top). By
2014, the proportion of fellows with outside mentors
increased markedly in the domains of research, setting
career goals, and achieving career goals (Figure 3, bottom).
As a result, the difference in the proportion of fellows and
senior faculty with outside mentoring was no longer
observed (P 5 not significant for all domains). No change
was observed in clinical or teaching domains. No change
was observed in the proportion of fellows and junior fac-
ulty who reported having no mentor in a domain.
Finally, we compared overall satisfaction with mentor-
ing before and after AMIGO. Both fellows and junior facul-
ty reported considerable satisfaction at baseline. An
improvement nevertheless emerged for fellows; a similar
but statistically nonsignificant trend was observed among
junior faculty. No change was observed among senior fac-
ulty (Figure 4).
DISCUSSION
Mentoring is a major contributor to career success in aca-
demic medicine (6). Recognizing a particular need for
improved access to mentoring in pediatric rheumatology,
the ACR and CARRA developed the AMIGO mentoring
program. The present study sought to assess whether AMIGO
conferred measurable value.
AMIGO participants were able to establish mentee-mentor
contact. The quality of mentee-mentor fit was largely pre-
served in the transition from pilot phase to general implemen-
tation, though a small decrement was apparent, potentially
Table 1. Respondents to pediatric rheumatology community surveys before and after AMIGO implementation*
Pre-AMIGO† Post-AMIGO‡
Total Fellows Junior faculty Senior faculty Total Fellows Junior faculty Senior faculty
No. 227 56 74 64 177 36 58 61
Women 122/184 (66) 40/52 (77) 48/67 (72) 28/55 (51) 105/165 (64) 27/36 (75) 39/58 (67) 32/60 (53)
AMIGO
participants
– – – – 100/170 (59)§ 31/36 (86) 29/58 (50)¶ 37/60 (62)
* Values are the number/total number (percentage) responding to each question, unless indicated otherwise. AMIGO 5 American College of Rheu-
matology/Childhood Arthritis Research and Rheumatology Alliance Mentoring Interest Group.
† Survey conducted from December 2011 to January 2012. Respondents who answered the questions on academic rank (n 5 194), on sex (n 5 184
[women, n 5 122; men, n 5 62]), and on both rank and sex (n 5 174).
‡ Survey conducted from February 2014 to March 2014. Respondents who answered the questions on academic rank (n 5 166), on sex (n 5 165),
and on AMIGO participation (n 5 170).
§ Includes respondents for whom no academic rank was provided.
¶ Of 58 junior faculty respondents, 18 (31%) participated as mentees and 17 (29%) as mentors, including 6 (10%) who participated both as ment-
ees and as mentors.
Figure 2. Proportion of fellow and junior faculty mentees report-
ing benefit from American College of Rheumatology/Childhood
Arthritis Research and Rheumatology Alliance Mentoring Interest
Group (AMIGO) in specific professional domains. Data reflect
n 5 31 fellows and n 5 18–28 junior faculty mentees from the
2014 survey of AMIGO participants. All comparisons are nonsig-
nificant via Fisher’s exact test.
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reflecting the lower ratio of available mentors to mentees in
later matches. Nevertheless, perceived utility was preserved,
suggesting no corresponding loss of program value. These
results confirm the feasibility of a subspecialty-wide interin-
stitutional mentoring program.
A major challenge facing mentoring initiatives is how to
evaluate overall impact (2,6). Programs have sought to mea-
sure success by assessing self-reported benefits (4,16,17) or
comparing participant outcomes to historical norms or to
those of program nonparticipants (16,18). These measures
are limited by the subjective nature of the responses, by
responder bias, and by selection bias arising through com-
parison of physicians who elect to enroll in such programs
with those who choose otherwise (6).
To understand the utility of AMIGO, we collected partici-
pant self-reports, identifying specific gains in career devel-
opment, scholarship, work-life balance, and connectedness
to the community. These findings support the overall design
of the program, but do not provide an objective assessment
of impact. Thus a unique strength of the AMIGO evaluation
strategy is that we also assessed the global state of mentoring
within pediatric rheumatology before and after program
implementation. Compared with pre-AMIGO data, fellows
in the post-AMIGO era reported better access to mentors out-
side their home institutions (we term this breadth of mentor-
ing) and in overall mentoring satisfaction. Modest trends in
the same direction could be identified for junior faculty,
potentially reflecting the much lower participation in this
subgroup (31% as mentees versus 86% among fellows).
Interestingly, areas of improved breadth of mentoring corre-
sponded closely with career domains in which AMIGO sur-
vey respondents also reported benefit (research and career
development), lending credibility to participant self-reports.
To our knowledge, these results represent the first evidence
that a structured program can alter the landscape of mentor-
ing within an entire medical discipline.
Implementation of AMIGO failed to reduce the proportion
of fellows or junior faculty who reported having no mentor
at all in specific domains. In part, this failure reflects a very
high baseline of self-reported access to a mentor of some
kind. For fellows, baseline access ranged from 70% to
almost 100%, depending on domain (Figure 3). These per-
centages are within the very broad range of self-reported
access to mentoring within medicine (2) and agree with a
previous report of access of mentoring during rheumatology
fellowship (19). Improvement above this very high back-
ground would have been challenging to achieve, in particu-
lar since participation in AMIGO was not ubiquitous.
However, having a network of mentors is well known to be
advantageous, particularly where these mentors bring differ-
ent perspectives (20). AMIGO mentors provide a view from
outside of the mentee’s institution, a perspective that is par-
ticularly helpful since many pediatric rheumatology pro-
grams are highly enriched for faculty who trained locally.
We are encouraged to observe that implementation of
AMIGO correlated with a striking increase in breadth of
mentoring for fellows, and we speculate that this
enhancement contributed to the overall improvement in
satisfaction with mentoring over this interval.
Participation in AMIGO was voluntary. Early career pedi-
atric rheumatologists may have elected not to participate in
AMIGO for many reasons. Some may have been too discon-
nected from the community to know about the program, or
engaged in a career path (for example, full-time clinical prac-
tice) for which they perceived no need of external mentoring.
Others may already have had satisfactory mentoring arrange-
ments, or perceived themselves as too established to benefit
from an AMIGO mentor. These factors likely explain why
Figure 3. Access to mentors in pediatric rheumatology. 2011 respondents were 54 fellows, 72 junior
faculty, and 59 senior faculty. 2014 respondents were 34 fellows, 57 junior faculty, and 57 senior facul-
ty. * 5 P , 0.05, ** 5 P , 0.01, via chi-square test.
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AMIGO participation as mentee was more penetrant among
fellows than junior faculty, where the ranks of instructor and
assistant professor encompass a great range of seniority.
Unsurprisingly, we could measure no concrete mentoring
gains in the junior faculty subgroup. Further evaluation using
qualitative methods may inform how to better serve this sub-
group, especially in the critical early years after fellowship.
We recognize important methodologic limitations to this
study. AMIGO mentees who experienced less benefit from
the program may have been less likely to complete the evalu-
ation surveys. If so, then participant reports overestimate the
benefits of AMIGO, though this caveat does not negate the
advantages experienced by those who did respond. The com-
munity surveys were cross-sectional assessments at 2 points
in time, and implementation of AMIGO was only 1 factor
varying over the intervening period. Response rates could
not be measured accurately. Thus, assessing the extent to
which our data reflect the community as a whole is difficult.
Despite these limitations, we are reassured that survey find-
ings are comparable to those of a 2012 survey of pediatric
rheumatology fellows and recent fellowship graduates that
found 78% to have no mentor outside their home institu-
tions (15). Further, participants in the 2011 and 2014 com-
munity surveys were demographically comparable, and
measures not likely to be affected by AMIGO (such as avail-
ability of clinical mentors, or mentoring for senior faculty)
remained largely stable. These internal controls suggest that,
at a minimum, intersurvey comparisons remain valid.
A final limitation of our program evaluation strategy is
that we made no attempt to measure concrete outcomes
such as retention in research, success obtaining extramural
funding, and rate of academic promotion. These important
outcomes were considered impracticable to assess mean-
ingfully, without a control group, in a cohort of the size
available within North American pediatric rheumatology.
The extent to which the AMIGO model can be general-
ized to adult rheumatology, or to other medical disci-
plines, remains to be determined. The small size of the
pediatric rheumatology community was one of the reasons
AMIGO was necessary but also helped to make AMIGO
feasible. Strong support by ACR and CARRA leadership,
within a collegial and well-integrated community, pro-
moted rapid and enthusiastic embrace of the program. Ear-
ly buy-in by stakeholders such as division chiefs and
fellowship directors facilitated mentee participation. The
small size of the community allowed the AMIGO Steering
Committee to tailor mentor-mentee matches, through
direct familiarity with many of the participants, particu-
larly at the mentor level. Similar personalization could be
more difficult in a larger subspecialty, such as adult
rheumatology.
A further important difference is that nonacademic clin-
ical practice is rare in pediatric rheumatology but common
in adult rheumatology. One option may therefore be to tar-
get an AMIGO-like program to adult rheumatology fellows
and junior faculty interested in academic careers. Such a
program could contribute to fostering the pipeline of
junior investigators required to secure a robust research
base in rheumatology, as suggested by the 2012 ACR Blue
Ribbon Panel on Academic Rheumatology and by the Ear-
ly Career Investigator Subcommittee of the ACR Commit-
tee on Research (9,21).
In summary, the AMIGO evaluation strategy confirms
both the feasibility and the utility of a subspecialty-wide
interinstitutional mentoring program in pediatric rheuma-
tology. Process measures document successful expansion
of AMIGO from the pilot phase through general enrollment.
Surveys of the general community before and after imple-
mentation of AMIGO confirm objective community-wide
gains that correlate closely to participant reports. Together,
these data support the investment in time, effort, and
resources that went into developing AMIGO and suggest
that analogous programs could be developed in adult rheu-
matology and potentially in other medical subspecialties.
Figure 4. Satisfaction with mentoring before and after American
College of Rheumatology/Childhood Arthritis Research and Rheu-
matology Alliance Mentoring Interest Group (AMIGO). Data com-
pare the baseline survey in 2010–2011 (light gray bars, n 5 53
fellows, 60 junior faculty, 57 senior faculty) and the post-AMIGO
survey in 2014 (dark gray bars, n 5 35 fellows, 57 junior faculty,
and 55 senior faculty). Fellows: P 5 0.01; junior faculty: P 5 non-
significant (ns); senior faculty: P 5 ns, via chi-square test.
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